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Group A streptococcus (GAS) is a highly prevalent bac-
terial pathogen that has been recovered from its human
hosts throughout the world. Most epidemiological studies
characterize GAS isolates by their emm type, a molecular
marker that has 200 distinct forms. The emm gene
encodes M protein, a surface fibril that is a major viru-
lence factor and target of protective immunity. Collection
of GAS, along with the molecular typing of isolates, has
been highly active throughout much of the world for the
past several decades. Within any one community over a 1-
or 2-year surveillance period, roughly 25 to 40 distinct emm
types can be detected among the GAS isolates.1–3 Each
host community has a unique array of emm types, and the
degree of overlap in the spectrum of emm types decreases
for host populations in rough proportion to their geograph-
ical distance. Even within the same community, the pre-
dominating emm types can shift from year to year.1
In this issue of The American Journal of Pathology, Fitti-
paldi et al4 present a magnified view of the unfolding
emergence and epidemic spread of an emm59 strain of
GAS. Before 2004, when the epidemic had its beginnings in
western Canada, recovery of emm59 isolates was rare.
Steer at al5 recently provided a meta-analysis of 100 re-
ports on GAS molecular epidemiology for 38,000 isolates
collected from 37 countries since 1980: in every region of
the world, emm59 strains are absent from the list of the 25
most prevalent emm types, even when those lists are further
stratified by disease. GAS isolates of emm type 59 were
largely below the radar before 2003, but have since ac-
counted for 540 cases of invasive disease in Canada.6
Generation of Epidemic emm59 GAS
How does an epidemic begin? One idea is that a pre-
existing strain finds itself in a new environment or in a new
host population, whereupon the conditions encountered
are favorable for its reproductive growth and sustained
transmission. Either the organism migrates to a new com-
1358munity, or the conditions within a community undergo a
drastic change. An alternative hypothesis states that a
genetic change in a bacterium leads to an increase in
fitness, which in turn leads to rapid spread of the new
genetic variant. The genetic change may have resulted in
acquisition of a new virulence factor or an antigenic shift,
leading to increased disease severity and/or enhanced
transmission. The fitness of a microorganism often re-
flects the host and/or environmental conditions, and each
genetic variant can experience a different level of fitness
within the same community. For example, if the new
bacterium undergoes a change in antigenic structure
and is present within an immunologically naïve host
population, the organism can experience a leap in fit-
ness whereby the conditions are now ripe for its clonal
expansion through enhanced transmission. This oc-
curred with serotype 19A pneumococcus after wide-
spread vaccination of the host population with the hep-
tavalent conjugate vaccine.7 For another example, if the
organism acquires an antibiotic resistance gene and is
present in an environment where antibiotic usage is high,
an outbreak with the new strain might occur. Positive
selection on the new genetic variant is the driving force
behind its expansion to epidemic proportions.
Fittipaldi et al4 present a reasonable argument that a
change in host and/or environmental conditions is un-
likely to have been a primary cause of the emm59 epi-
demic, because none of the other coexisting GAS strains
experienced a similar surge in prevalence within the
same communities. Thus, a genetic mechanism likely
produced the epidemic emm59 organism. The authors
examined the genetic differences that distinguish historic
emm59 isolates from the contemporary epidemic emm59
isolates. By mapping such genetic differences, they
sought to identify gene candidates that may be respon-
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the epidemic. To do this, the authors exploited advances
in next-generation sequencing technology and deter-
mined the nucleotide sequence of the genomes of 600
isolates of emm59 GAS. Initially using one representative
historic and one epidemic isolate for comparison, 150
single-nucleotide polymorphisms (SNPs) or indels (inser-
tions or deletions) were uncovered within the core ge-
nome. In addition, the epidemic isolate lost one prophage
(which harbored two virulence genes, a superantigen
and phospholipase) and gained a prophage remnant at
another locus, relative to the historic isolate. Might the
loss of a virulence gene have led to the epidemic? Do any
of the SNPs or indels lie within or adjacent to genes
having an established role in GAS virulence? That anal-
ysis is currently ongoing at the authors’ laboratory.
Is it possible that the genetic change hypothesis is incor-
rect? It is possible, but another strong argument weighs
heavily in favor of this hypothesis. Fittipaldi et al4 used
animal models to test the virulence of representative historic
and contemporary emm59 isolates. Under three different
models for infection of normally sterile soft tissue after injec-
tion of bacteria at a subcutaneous or intramuscular site, the
epidemic emm59 isolates displayed significantly greater
virulence than the historic isolate. The animal findings show-
ing differences in virulence provide supporting evidence
that changes in virulence capacity evolved only recently.
Thus, it appears that there may be a genetic change (yet to
be defined) underlying the emm59 epidemic.
Tissue-Specific Properties of the Epidemic
emm59 Strain
Invasive disease accounts for a large measure of mor-
bidity and mortality due to GAS; however, infection at
superficial epithelial tissue sites is far more prevalent.8 It
is from the superficial tissue sites that most person-to-
person transmission initiates. The most highly prevalent
infections caused by GAS are pharyngitis and nonbullous
impetigo. GAS is also associated with asymptomatic car-
riage at the throat; among school-aged children, the car-
riage rate often exceeds 20%. Compared with under-
standing of oropharyngeal carriage, there is less of an
understanding of GAS colonization of normal skin. How-
ever, in one seminal prospective surveillance study in-
volving children living on the Red Lake Indian Reserva-
tion (in northern Minnesota), where GAS pyoderma was
endemic, GAS was frequently isolated from normal skin
before the development of impetigo lesions.9 Thus, the
primary reservoirs for GAS are the oropharyngeal mu-
cosa and skin, and these tissues accommodate both
carriage and infectious processes.
Within just a few years, emm59 GAS in Canada rose
from being rare to becoming the most common cause of
invasive GAS infections, accounting for 13% of all inva-
sive isolates collected over a 4-year period.6 However, no
parallel rise in emm59 GAS isolates associated with phar-
yngitis occurred, with emm59 accounting for 0.5% of
total pharyngitis isolates.4 Thus, if the emm59 strain is
transmitted primarily through a respiratory route, either itis extraordinarily virulent and has a very high invasive
index, or there is a very strong tendency toward an
asymptomatic course when colonizing the oropharynx.
The far more likely explanation is that the primary mode of
transmission for emm59 strains is via skin contact.
Fittipaldi et al4 have begun to investigate the tissue-
specific properties of the epidemic emm59 strain by com-
parison with an emm1 GAS strain (MGAS5005); emm1 is
among the most prevalent emm types recovered from
cases of pharyngitis in the United States and Canada in
recent years.1 The emm1 and emm59 strains were com-
pared for survival and growth in human saliva,10 where
essential nutrients may be limiting and antimicrobial pep-
tides may be active. The emm1 strain exhibited signifi-
cantly greater survival in human saliva than the epidemic
emm59 strain. The emm1 strain also showed significantly
higher levels of colonization in a mouse oropharyngeal
model. The findings support the notion that the MGAS5005
strain has a significantly higher tropism for the throat, com-
pared with the epidemic emm59 strain.
In contrast to the experimental models for throat infection,
in a newly developed model for mouse skin lesions the
emm1 and emm59 isolates showed equivalent levels of
skin-to-skin transmission.4 Thus, the collective data suggest
that the emm1 strain is highly effective at infecting both
throat and skin; the latter finding has strong epidemiological
support in the high association of emm1 strains with soft-
tissue infection. However, the MGAS5005 strain (emm1)
under study is a sterile-site isolate with a mutation in the
global transcriptional regulator gene covS and, conse-
quently, exhibits the invasive transcriptome profile (TP), as
opposed to the pharyngitis TP.11 Perhaps the invasive TP of
MGAS5005 provides an explanation for why this isolate
effectively transmits in the mouse skin lesion model (a full-
thickness incision), particularly if infection is established by
introduction of bacteria into subepithelial tissue.12 However,
why an invasive TP strain such as MGAS5005 has a high
capacity for oropharyngeal colonization is not entirely clear.
Both the invasive TP and the pharyngitis TP are associated
with invasive disease, but mounting evidence suggests that
the pharyngitis TP is essential for infection of the throat.11–13
In some ways, the findings of Fittipaldi et al4 raise more
questions than they provide answers, and the streptococcal
field as a whole may need to reconcile these data in the
future. The transcriptome profiles of the epidemic and his-
toric emm59 strains were not reported,4 and this points to
another ripe avenue for future investigations.
Experimental data suggest that the emm1 strain has a
higher affinity for the throat than does the emm59 strain. This
finding gains additional support from epidemiological data
showing that the emm59 strain is recovered only rarely from
cases of pharyngitis. Superficial tissue site preferences for
infection (ie, throat versus skin) for individual GAS strains
have long been noted.14 A useful biomarker for preferred
tissue sites of infection is found in the emm pattern geno-
type, which is based on the 3= ends of emm genes. There
are three distinct genotype-defined groups: throat special-
ists causing pharyngitis (patterns A, B, and C), skin spe-
cialists causing impetigo (pattern D), and generalists, which
as a group have no overriding preference (pattern E).15
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dian emm59/ST172 isolates examined by other investiga-
tors in earlier studies; all were pattern D (skin special-
ists).16,17 In a recent study comparing the accessory
gene regions of GAS strains of 90 different emm
types,15 all but a few pattern D strains are associated with
a single tight, genetically related cluster. The atypical
pattern D exceptions include emm59, emm81, and
emm85 strains, each of which have the sof gene, which is
otherwise a distinguishing feature of pattern E strains. In
fact, the emm59, emm81, and emm85 pattern D strains
tend to group with the majority of pattern E strains and
harbor pilus-encoding fibronectin-collagen-T (FCT) ge-
netic regions that are also more typical of those of pattern
E strains. Recently, emm85 isolates have been recovered
from impetigo lesions in a tropical Australian community.2
In a London (UK) hospital, emm81 isolates obtained from
a variety of wound and soft-tissue infections in patients
had the highest prevalence among all emm types.18 An
emm81 strain was recently associated with an outbreak
of ulcerated skin lesions (ecthyma) among Israeli sol-
diers.19 The atypical pattern D strains having a pattern
E-like genotype (ie, emm59, emm81, and emm85) may
possess factors that are required to initiate infection at
the skin. However, unlike the typical pattern D strains,
which tend to be associated with impetigo and are seem-
ingly uncommon causes of invasive disease, the atypical
pattern D strains may have an enhanced capacity for
gaining access to deeper tissue. Future studies that ex-
amine the genetic similarities and differences between
atypical pattern D strains and the typical pattern D and E
strains may uncover the virulence factors critical for the
initial skin infection and those necessary for subsequent
invasion into deeper tissue.
Most of the Canadian cases of invasive disease caused
by the emm59 strain involved bacteremia or cellulitis, al-
though there were also several instances of necrotizing
fasciitis.6 The age distribution of invasive disease due to
emm59 was strikingly different from nonbullous impetigo,
which affects primarily children (although adults also can
have impetigo).8 In the Canadian epidemic, there was a
peak incidence of invasive disease involving infants,
which dropped sharply by 2 years of age and rose again
to a high level for patients 25 to 60 years of age.6 In
addition, there were several notable risk factors for inva-
sive disease caused by the emm59 strain, which were
significant compared with all other GAS strains causing
invasive disease within the very same communities. The
risk factors for emm59 invasive disease included alcohol
abuse and illicit drug use, homelessness, and hepatitis C
virus infection.6 Thus, the emm59 strain epidemic may
have originated and/or been amplified within a disadvan-
taged host population.
Additional Genetic Data on emm59
Emergence
Data on multilocus sequencing typing (MLST) of GAS are
available in a valuable resource compiled by investigators
from throughout the world. Five emm59/ST172 isolates arelisted in the MLST database (http://spyogenes.mlst.net;
last accessed January 2, 2012). Of these, the oldest
emm59 isolate was recovered from an impetigo lesion in
the U.S. in 1969. Three other emm59 isolates originated
from normally sterile tissue sites. The fifth emm59/ST172
isolate (strain 149405, a blood isolate from the Czech
Republic collected in 2004) was tested for resistance to
antibiotics; it is reported to be susceptible to erythromy-
cin and clindamycin, but resistant to tetracycline. Fitti-
paldi et al4 also report historic emm59/ST172 strains from
Japan and Spain.
Another plausible hypothesis for the emm59 epidemic
is migration of an established clone into a new commu-
nity, whereby the new host population and/or the new
environment have risk factors that, in turn, enable the new
migrant to grab a foothold and quickly spread. Tetracy-
cline resistance in GAS is widespread among numerous
emm types and typically arises via newly acquired resis-
tance genes (as opposed to mutation of core genes).
Nonetheless, no such genomic distinctions in antibiotic
resistance genes were reported for the historic versus
Canadian epidemic emm59 strains,4 raising the reason-
able possibility that all of the emm59 strains are tetracy-
cline-resistant, like the sole emm59 isolate reportedly
tested after its recovery in the Czech Republic. Because
tetracycline is not a recommended treatment for GAS
infections, there are few recognized treatment failures,
and resistance to this antibiotic often goes unnoticed.
However, if a tetracycline-resistant strain migrates into a
community having unusually high tetracycline usage,
there may be enough positive selection pressure for the
strain to reproduce and increase in numbers to exceed a
critical threshold, thereby yielding sufficient penetration
in the community to support its continual transmission to
new hosts. Macrolide consumption is a key factor leading
to increased prevalence of macrolide-resistant GAS,20
which is often rooted in a heterogeneous set of geneti-
cally distinct clones. However, a sharp increase in prev-
alence of macrolide-resistant GAS can also be due to a
single dominant clone.21 Knowledge of the antibiotic resis-
tance profiles of the Canadian emm59 strains is critical
information that can aid in a more thorough consideration of
the possible mechanisms by which the epidemic arose,
because the selective pressure exerted by antibiotics is
among the strongest to which bacteria are subject.
It remains possible that the epidemic emm59 clone
existed elsewhere in the world for a long period of time,
emerging to cause an epidemic in Canada because of
unknown host or environmental risk factors that are
uniquely specific to the emm59 clone. Alternatively, the
initial rise in prevalence of a migrant may be due to
entirely random factors. It is also plausible that the con-
temporary emm59 clone is not rare but, rather, is abun-
dant in an undersampled region. Although surveillance
for GAS is extensive, in many pockets of the world, par-
ticularly much of Africa and parts of Asia, there is a dearth
of surveillance reports. Of the38,000 isolates evaluated
in a meta-analysis of GAS surveillance studies,5 the vast
majority of organisms (32,000) originate from countries
with market economies. Another possible scenario is that
the emm59 clone persisted in a region that does indeed
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cause an extensive degree of severe disease because
the host and/or environmental risk factors did not align. If
the emm59 clone that caused the Canadian epidemic
was a migrant, it may not be ancestral to the historic
isolates from Japan, Spain, and the U.S. that were ana-
lyzed by Fittipaldi et al.4 However, from the standpoint of
using genomic analysis to map genetic differences that
may have given rise to differences in virulence proper-
ties, the direction of the ancestral-descendant pathway
probably does not matter.
The genome sequencing of 600 emm59 GAS iso-
lates clearly shows the epidemic spread of a single clone
over a very short period of evolutionary time.4 Genes
previously identified in organisms of other emm types as
being highly variable, such as emm type, which is often
under intense immune selection favoring genetic variants
display unusual genetic stability among the emm59 iso-
lates. The genes covS and rgg, which encode global
transcriptional regulators that affect the pharyngitis TP to
invasive TP transition are also highly variable in other
GAS strains, yet display unusual genetic stability among
the emm59 isolates. On the other hand, genetic changes in
clustered regularly interspaced short palindromic repeat
elements (CRISPR elements) helped confirm the genotype
that was most likely present at the onset of the epidemic.
Another surprise was the relatively high number of SNPs in
another transcriptional regulatory gene (mga) of GAS. The
phylogenetic tree based on concatenated SNPs reveals
deep branches between each of the historic isolates col-
lected from three distant regions of the world and the recent
Canadian epidemic isolates. Compared with the genomes
of GAS of numerous additional emm types, however, the
relative genetic distance between the historic and contem-
porary emm59 isolates is miniscule.
Concluding Remarks
If a genetic change helped spark the emm59 epidemic in
Canada, the genetic differences between the historic and
contemporary isolates require closer evaluation. At least
during initial analysis, the strongest candidates will be vari-
ant genes whose role in GAS virulence is already well es-
tablished. For an optimal experimental test, genetic swap
mutants could be constructed whereby the genetic varia-
tion present in the epidemic strain is introduced into a his-
toric strain and vice versa. Using appropriate animal mod-
els, a finding of increased virulence by the modified historic
strain, and decreased virulence by the modified contempo-
rary strain, would support cause and effect and thus would
close the circle on the genetic change hypothesis.
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